To: Aihua Pharmaceutical Group Co., Ltd.
Aihua Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") will hold its first extraordinary shareholders' meeting in 2026 (hereinafter referred to as "the Meeting") on February 26, 2026, at 13:00 in the conference room of the Company located at 18 Hunan Road, Aihua Pharmaceutical Group Co., Ltd., Beijing. The law firm of Tian Yuan has provided legal opinions regarding the Meeting, indicating that the Meeting complies with the Company Law, the Articles of Association, and other relevant regulations.
In order to provide legal opinions, the law firm has reviewed the Meeting's agenda and relevant documents, ensuring that the Meeting's procedures and outcomes are legally valid.
I. Meeting Agenda and Procedures
The Company will hold the Meeting on February 9, 2026, to decide on the agenda. The Meeting will be conducted through a combination of on-site voting and online voting. The Meeting will take place at the conference room of the Company at 18 Hunan Road, Aihua Pharmaceutical Group Co., Ltd., Beijing, from 9:15 to 11:30 and from 13:00 to 15:00 on February 26, 2026.
The Meeting will adopt a method of on-site voting combined with online voting. The specific details of the Meeting will be communicated through the Company’s official channels.
II. Qualifications of Shareholders Attending the Meeting
The shareholders attending the Meeting include 353 representatives, holding a total of 293,917,545 shares, accounting for 50.3283% of the total shares of the Company. Among them, 4 representatives hold 289,222,600 shares, accounting for 49.5244% of the total shares.